Clinical trial
Efficacy and Safety Study of the Fixed-dose Combination of Celecoxib/Acetaminophen Compared to Celecoxib for the Treatment of Pain in Patients Diagnosed With Osteoarthritis in Acute Exacerbation
NCT06863636 is registered in ClinicalTrials.gov with Laboratorios Silanes S.A. de C.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety Study of the Fixed-dose Combination of Celecoxib/Acetaminophen Compared to Celecoxib for the Treatment of Pain in Patients Diagnosed With Osteoarthritis in Acute Exacerbation
- Lead sponsor
- Laboratorios Silanes S.A. de C.V.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 9, 2024
- Completion date
- November 30, 2025
- Enrollment
- 231 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hip osteoarthritis, joint pain, knee osteoarthritis